NASDAQ: JYNTJoint Corp Stock
$13.85-0.43 (-3.01%)
Updated Jun 2, 2023
JYNT Price
$13.85
Fair Value Price
$14.84
Market Cap
$203.30M
52 Week Low
$12.85
52 Week High
$25.25
P/E
55.4x
P/B
5.8x
P/S
2.27x
PEG
2.31x
Dividend Yield
N/A
Revenue
$107.92M
Earnings
$3.68M
Gross Margin
90.6%
Operating Margin
4.89%
Profit Margin
3.4%
Debt to Equity
1.8
Operating Cash Flow
$17M
Beta
1.2
Next Earnings
Aug 2, 2023
Ex-Dividend
N/A
Next Dividend
N/A
JYNT Overview
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how JYNT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
JYNT ($13.85) is undervalued by 6.7% relative to our estimate of its Fair Value price of $14.84 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
JYNT ($13.85) is not significantly undervalued (6.7%) relative to our estimate of its Fair Value price of $14.84 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
JYNT ($13.85) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more JYNT due diligence checks available for Premium users.
Be the first to know about important JYNT news, forecast changes, insider trades & much more!
JYNT News
Valuation
JYNT fair value
Fair Value of JYNT stock based on Discounted Cash Flow (DCF)
Price
$13.85
Fair Value
$14.84
Undervalued by
6.70%
JYNT ($13.85) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
JYNT ($13.85) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
JYNT ($13.85) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
JYNT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
55.4x
Industry
8.83x
Market
52.69x
JYNT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
JYNT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
JYNT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.8x
Industry
4.58x
JYNT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
JYNT price to earnings growth (PEG)
For valuing profitable companies with growth potential
JYNT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
JYNT's financial health
Profit margin
Revenue
$28.5M
Net Income
$2.3M
Profit Margin
8.1%
JYNT's Earnings (EBIT) of $5.28M... subscribe to Premium to read more.
Interest Coverage Financials
JYNT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$98.1M
Liabilities
$62.9M
Debt to equity
1.8
JYNT's short-term liabilities ($24.97M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
JYNT's long-term liabilities ($37.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
JYNT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
JYNT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$6.0M
Investing
-$1.2M
Financing
$129.8k
JYNT's operating cash flow ($16.66M)... subscribe to Premium to read more.
Debt Coverage Financials
JYNT vs Medical Care Facility Stocks
Joint Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.